Citation Impact
Citing Papers
2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM Guidelines for the Diagnosis and Management of Patients With Thoracic Aortic Disease
2010 Standout
Discovery and inhibition of an interspecies gut bacterial pathway for Levodopa metabolism
2019 Science
PROCEEDINGS OF THE BRITISH PHARMACOLOGICAL SOCIETY
1971 StandoutNobel
Clinical Pharmacokinetics of the Newer ACE Inhibitors
1990
Diagnosis of Tuberculous Pleural Effusion by the Detection of Tuberculostearic Acid in Pleural Aspirates
1991
Emerging Strategies to Combat ESKAPE Pathogens in the Era of Antimicrobial Resistance: A Review
2019 Standout
Parkinson's disease
2021 Standout
Development of oral controlled release preparations, a PVA swelling controlled release system (SCRS) I. Design of SCRS and its release controlling factor
2000
Gastrointestinal dysfunction in Parkinson's disease
2003 Standout
Management of acute organophosphorus pesticide poisoning
2007 Standout
Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes
2016 Standout
Effect of Captopril on Mortality and Morbidity in Patients with Left Ventricular Dysfunction after Myocardial Infarction
1992 Standout
Captopril
1988
Perioperative Management of Antithrombotic Therapy
2012 Standout
Emergency Hospitalizations for Adverse Drug Events in Older Americans
2011 Standout
Aging Biology and Geriatric Clinical Pharmacology
2004
On the origin of the catalytic power of carboxypeptidase A and other metalloenzymes
2009 StandoutNobel
Effect of Oral Milrinone on Mortality in Severe Chronic Heart Failure
1991 Standout
Age‐related changes in pharmacokinetics and pharmacodynamics: basic principles and practical applications
2003 Standout
Hydrogel nanoparticles in drug delivery
2008 Standout
Role of the N-terminal Catalytic Domain of Angiotensin-converting Enzyme Investigated by Targeted Inactivation in Mice
2004 StandoutNobel
Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors: the CHARM-Added trial
2003 Standout
Optimal patient position for transport and initial management of toxic ingestions
1992
Characteristics and Quality of Prescribing by Doctors Practicing in Nursing Homes
1993
A Randomized Trial of the Angiotensin-Receptor Blocker Valsartan in Chronic Heart Failure
2001 Standout
Pharmacokinetic-Pharmacodynamic Crisis in the Elderly
2006
Liver Function and Phase I Drug Metabolism in the Elderly
2001
Angiotensin II promotes atherosclerotic lesions and aneurysms in apolipoprotein E–deficient mice
2000 Standout
Isolation of a cDNA encoding the vascular type-1 angiotensin II receptor
1991 StandoutNature
Appropriate prescribing in elderly people: how well can it be measured and optimised?
2007 Standout
Randomised trial of losartan versus captopril in patients over 65 with heart failure (Evaluation of Losartan in the Elderly Study, ELITE)
1997 Standout
Diagnosis and Treatment of Tuberculous Pleural Effusion in 2006
2007 Standout
Gastric emptying time and gastric motility in patients with Parkinson's disease
2001
Enzyme induction in the cytochrome P-450 system
1990 Standout
Cytochrome P450 enzymes in drug metabolism: Regulation of gene expression, enzyme activities, and impact of genetic variation
2013 Standout
The Current State of Knowledge on Age, Sex, and Their Interactions on Clinical Pharmacology
2007
Beneficial effects of milrinone and enalapril on long-term survival of rats with healed myocardial infarction
1988
Alzheimer and platelets: Low-density platelet populations reveal increased serotonin content in Alzheimer type dementia
2014 StandoutNobel
Lack of angiotensin II–facilitated erythropoiesis causes anemia in angiotensin-converting enzyme–deficient mice
2000 StandoutNobel
Effects of enalapril on mortality in severe congestive heart failure: Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS)
1988 Standout
Aggrenox: A Fixed-Dose Combination of Aspirin and Dipyridamole
2000
Molecular Recognition of Protein−Ligand Complexes: Applications to Drug Design
1997 Standout
Studies on digitalis
1977
Prostacyclin and Blood Coagulation
1981 StandoutNobel
2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM Guidelines for the Diagnosis and Management of Patients With Thoracic Aortic Disease
2010 Standout
Comparative Effects of Low and High Doses of the Angiotensin-Converting Enzyme Inhibitor, Lisinopril, on Morbidity and Mortality in Chronic Heart Failure
1999 Standout
Genetic Influences on Plasma and Urinary Norepinephrine after Volume Expansion and Contraction in Normal Men*
1980
Angiotensin-Converting Enzyme Gene Polymorphism Has No Influence on the Circulating Renin-Angiotensin-Aldosterone System or Blood Pressure in Normotensive Subjects
1995
Augmented Short- and Long-Term Hemodynamic and Hormonal Effects of an Angiotensin Receptor Blocker Added to Angiotensin Converting Enzyme Inhibitor Therapy in Patients With Heart Failure
1999
Guidelines for the early management of patients with acute myocardial infarction
1990
Contribution of the Lung to Total Body Clearance of Meperidine in the Dog
1985 StandoutNobel
Platelets, Thrombosis and Drugs
1975
Metabolic Interactions Among Environmental Chemicals and Drugs
1972 Science
The clinical application of the biopsychosocial model
1980 Standout
Strategies in Herbivory by Mammals: The Role of Plant Secondary Compounds
1974 Standout
Overexpression of angiotensin AT 1 receptor transgene in the mouse myocardium produces a lethal phenotype associated with myocyte hyperplasia and heart block
1997 StandoutNobel
Arterial walls are protected against deposition of platelet thrombi by a substance (prostaglandin X) which they make from prostaglandin endoperoxides
1976 StandoutNobel
Mice Lacking Endothelial ACE
2003 StandoutNobel
Tuberculous Pleurisy
1973
Some Central and Peripheral Effects of Meclastine, a New Antihistaminic Drug, in Man
1971
Role of Angiotensin Converting Enzyme Inhibitors in Essential and Renal Hypertension
1984
?On-off? phenomenon in Parkinson's disease: Correlation to the concentration of dopa in plasma
1984 StandoutNobel
Management of Massive and Submassive Pulmonary Embolism, Iliofemoral Deep Vein Thrombosis, and Chronic Thromboembolic Pulmonary Hypertension
2011 Standout
Enalapril
1986
Enalapril: A new angiotensin-converting enzyme inhibitor in chronic heart failure: Acute and chronic hemodynamic evaluations
1983
ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease
2006 Standout
Angiotensin-Converting Enzyme Inhibitors
1998
The human pharmacology of GB 94 — a new psychotropic agent
1973
A New Depression Scale Designed to be Sensitive to Change
1979 Standout
Antipurified-Protein-Derivative Antibody in Tuberculous Pleural Effusions
1990 StandoutNobel
FTIR spectroscopy characterization of poly (vinyl alcohol) hydrogel with different hydrolysis degree and chemically crosslinked with glutaraldehyde
2007 Standout
Difficulties in assessing adverse drug reactions in clinical trials
1982
The Design and Properties of N‐Carboxyalkyldipeptide Inhibitors of Angiotensin‐Converting Enzyme
1985
The effect of hyperemia on spinal cord function after temporary thoracic aortic occlusion
1988
ACE inhibition with perindopril and atherogenesis-induced structural and functional changes in minipig arteries.
1993
Comparison of Captopril and Enalapril in Patients with Severe Chronic Heart Failure
1986
Clinical Implications of Enzyme Induction and Enzyme Inhibition
1981
An overview of the clinical pharmacology of enalapril.
1984
Blood platelets as a model for monoamine-containing neurones
1973
DOPA and amino acid levels in plasma and cerebrospinal fluid of patients with parkinson's disease before and during treatment with L-dOPA
1973
Variability of L-Dopa Absorption in Man
1974
Mice Lacking Endothelial Angiotensin-Converting Enzyme Have a Normal Blood Pressure
2002 StandoutNobel
Lipopolysaccharide Endotoxins
2002 Standout
The UKU side effect rating scale: A new comprehensive rating scale for psychotropic drugs and a cross‐sectional study of side effects in neuroleptic‐treated patients
1987 Standout
Meropenem and Vaborbactam: Stepping up the Battle against Carbapenem‐resistant Enterobacteriaceae
2018
Behavioural despair in rats: A new model sensitive to antidepressant treatments
1978 Standout
Psychologic Stress, Vasodepressor (Vasovagal) Syncope, and Sudden Death
1978
Cardiovascular drugs in children: Angiotensin-converting enzyme inhibitors
1988
Clinical Pharmacokinetics Pethidine
1978
Uptake of 14C-5-hydroxytryptamine by human and rat platelets and its pharmacological inhibition
1976
Functional Gastrointestinal Disorders: History, Pathophysiology, Clinical Features, and Rome IV
2016 Standout
Recent developments in the design of angiotensin‐converting enzyme inhibitors
1985
Prescribed drugs containing nitrogen heterocycles: an overview
2020 Standout
Definitions and characteristics of sodium sensitivity and blood pressure resistance.
1986 Standout
Sustained improvement of pulmonary hemodynamics in patients at rest and during exercise after thrombolytic treatment of massive pulmonary embolism.
1985
Works of William B. Abrams being referenced
Clinical pharmacology in an aging population
1998
Task force IV: Pharmacologie interventions
1982
Effect of food on the absorption of enteric-coated aspirin: Correlation with gastric residence time
1987
Current Concepts of Tuberculous Pleurisy with Effusion as Derived from Pleural Biopsy Studies
1960
The influence of debrisoquin on the accumulation and metabolism of biogenic amines by the human platelet, in vivo and in vitro
1969
The role of catecholamines in producing arrhythmias
1971
Some effects of a new antiarrhythmie drug
1961
Geriatric Clinical Pharmacology
1986
Interactions between digitoxin and other drugs in man
1972
Drugs and the elderly.
1985
Pharmacokinetics of meperidine in man
1976
Synergistic antihypertensive effect of MK-421 and hydrochlorothiazide
1982
Three new long-acting converting-enzyme inhibitors: Relationship between plasma converting-enzyme activity and response to angiotensin I
1981
Clinical pharmacology of enalapril.
1984
INTERACTIONS BETWEEN DIGITOXIN AND OTHER DRUGS IN VITRO AND IN VIVO
1971
A new approach to the use of histamine skin tests in the study of antihistamine drugs
1969
The Mechanisms of Action of Antihypertensive Drugs
1969
The accumulation and metabolism of dopamine by the human platelet
1970
The human platelet as a pharmacologic model for the adrenergic neuron
1969
Absorption and Metabolism of Levodopa
1971
Introducing a New Drug into Clinical Practice
1971